Primary and secondary hemostasis in patients with subclinical hypothyroidism: Effect of levothyroxine treatment

Roberta Lupoli, Matteo Nicola Dario Di Minno, Anna Tortora, Alessandra Scaravilli, Marianna Cacciapuoti, Livia Barba, Alessandro Di Minno, Pasquale Ambrosino, Gelsy Arianna Lupoli, Giovanni Lupoli

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Context: Subclinical hypothyroidism (SH) is associated with some abnormalities in primary and secondary hemostasis. Objective: The objective of the study was to evaluate changes in primary and secondary hemostasis induced by levothyroxine (L-T4) treatment in SH patients. Design: This was a prospective cohort study with a 6-month follow-up. Study Setting: Outpatients were referred to "Federico II" University of Naples. Patients: Subjects with a SH without previous/ongoing L-T4 therapy participated in the study. Main Outcome Measure: Changes in major hemostatic/fibrinolytic variables and platelet reactivity [mean platelet volume (MPV), arachidonic acid (AA), or ADP concentrations inducing a ≥ 50% irreversible aggregation (AC-50%)] in SH patients before and after a 6-month L-T4 treatment. Results: At baseline, 41 SH patients showed higher levels of factor VII activity (123.9±20.4 vs 107.7±12.2, P

Original languageEnglish
Pages (from-to)2659-2665
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume100
Issue number7
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Platelets
Hypothyroidism
Hemostasis
Thyroxine
Factor VII
Hemostatics
Arachidonic Acid
Adenosine Diphosphate
Agglomeration
Mean Platelet Volume
Therapeutics
Cohort Studies
Outpatients
Blood Platelets
Outcome Assessment (Health Care)
Prospective Studies

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Lupoli, R., Di Minno, M. N. D., Tortora, A., Scaravilli, A., Cacciapuoti, M., Barba, L., ... Lupoli, G. (2015). Primary and secondary hemostasis in patients with subclinical hypothyroidism: Effect of levothyroxine treatment. Journal of Clinical Endocrinology and Metabolism, 100(7), 2659-2665. https://doi.org/10.1210/jc.2015-1726

Primary and secondary hemostasis in patients with subclinical hypothyroidism : Effect of levothyroxine treatment. / Lupoli, Roberta; Di Minno, Matteo Nicola Dario; Tortora, Anna; Scaravilli, Alessandra; Cacciapuoti, Marianna; Barba, Livia; Di Minno, Alessandro; Ambrosino, Pasquale; Lupoli, Gelsy Arianna; Lupoli, Giovanni.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 100, No. 7, 01.07.2015, p. 2659-2665.

Research output: Contribution to journalArticle

Lupoli, R, Di Minno, MND, Tortora, A, Scaravilli, A, Cacciapuoti, M, Barba, L, Di Minno, A, Ambrosino, P, Lupoli, GA & Lupoli, G 2015, 'Primary and secondary hemostasis in patients with subclinical hypothyroidism: Effect of levothyroxine treatment', Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 7, pp. 2659-2665. https://doi.org/10.1210/jc.2015-1726
Lupoli, Roberta ; Di Minno, Matteo Nicola Dario ; Tortora, Anna ; Scaravilli, Alessandra ; Cacciapuoti, Marianna ; Barba, Livia ; Di Minno, Alessandro ; Ambrosino, Pasquale ; Lupoli, Gelsy Arianna ; Lupoli, Giovanni. / Primary and secondary hemostasis in patients with subclinical hypothyroidism : Effect of levothyroxine treatment. In: Journal of Clinical Endocrinology and Metabolism. 2015 ; Vol. 100, No. 7. pp. 2659-2665.
@article{576f693506164ba9946ffca0f3bdbea1,
title = "Primary and secondary hemostasis in patients with subclinical hypothyroidism: Effect of levothyroxine treatment",
abstract = "Context: Subclinical hypothyroidism (SH) is associated with some abnormalities in primary and secondary hemostasis. Objective: The objective of the study was to evaluate changes in primary and secondary hemostasis induced by levothyroxine (L-T4) treatment in SH patients. Design: This was a prospective cohort study with a 6-month follow-up. Study Setting: Outpatients were referred to {"}Federico II{"} University of Naples. Patients: Subjects with a SH without previous/ongoing L-T4 therapy participated in the study. Main Outcome Measure: Changes in major hemostatic/fibrinolytic variables and platelet reactivity [mean platelet volume (MPV), arachidonic acid (AA), or ADP concentrations inducing a ≥ 50{\%} irreversible aggregation (AC-50{\%})] in SH patients before and after a 6-month L-T4 treatment. Results: At baseline, 41 SH patients showed higher levels of factor VII activity (123.9±20.4 vs 107.7±12.2, P",
author = "Roberta Lupoli and {Di Minno}, {Matteo Nicola Dario} and Anna Tortora and Alessandra Scaravilli and Marianna Cacciapuoti and Livia Barba and {Di Minno}, Alessandro and Pasquale Ambrosino and Lupoli, {Gelsy Arianna} and Giovanni Lupoli",
year = "2015",
month = "7",
day = "1",
doi = "10.1210/jc.2015-1726",
language = "English",
volume = "100",
pages = "2659--2665",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Primary and secondary hemostasis in patients with subclinical hypothyroidism

T2 - Effect of levothyroxine treatment

AU - Lupoli, Roberta

AU - Di Minno, Matteo Nicola Dario

AU - Tortora, Anna

AU - Scaravilli, Alessandra

AU - Cacciapuoti, Marianna

AU - Barba, Livia

AU - Di Minno, Alessandro

AU - Ambrosino, Pasquale

AU - Lupoli, Gelsy Arianna

AU - Lupoli, Giovanni

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Context: Subclinical hypothyroidism (SH) is associated with some abnormalities in primary and secondary hemostasis. Objective: The objective of the study was to evaluate changes in primary and secondary hemostasis induced by levothyroxine (L-T4) treatment in SH patients. Design: This was a prospective cohort study with a 6-month follow-up. Study Setting: Outpatients were referred to "Federico II" University of Naples. Patients: Subjects with a SH without previous/ongoing L-T4 therapy participated in the study. Main Outcome Measure: Changes in major hemostatic/fibrinolytic variables and platelet reactivity [mean platelet volume (MPV), arachidonic acid (AA), or ADP concentrations inducing a ≥ 50% irreversible aggregation (AC-50%)] in SH patients before and after a 6-month L-T4 treatment. Results: At baseline, 41 SH patients showed higher levels of factor VII activity (123.9±20.4 vs 107.7±12.2, P

AB - Context: Subclinical hypothyroidism (SH) is associated with some abnormalities in primary and secondary hemostasis. Objective: The objective of the study was to evaluate changes in primary and secondary hemostasis induced by levothyroxine (L-T4) treatment in SH patients. Design: This was a prospective cohort study with a 6-month follow-up. Study Setting: Outpatients were referred to "Federico II" University of Naples. Patients: Subjects with a SH without previous/ongoing L-T4 therapy participated in the study. Main Outcome Measure: Changes in major hemostatic/fibrinolytic variables and platelet reactivity [mean platelet volume (MPV), arachidonic acid (AA), or ADP concentrations inducing a ≥ 50% irreversible aggregation (AC-50%)] in SH patients before and after a 6-month L-T4 treatment. Results: At baseline, 41 SH patients showed higher levels of factor VII activity (123.9±20.4 vs 107.7±12.2, P

UR - http://www.scopus.com/inward/record.url?scp=84942302233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942302233&partnerID=8YFLogxK

U2 - 10.1210/jc.2015-1726

DO - 10.1210/jc.2015-1726

M3 - Article

C2 - 25955227

AN - SCOPUS:84942302233

VL - 100

SP - 2659

EP - 2665

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -